Leslie Spangler1, Laura E Ichikawa2, Rebecca A Hubbard2, Belinda Operskalski2, Andrea Z LaCroix3, Susan M Ott4, Delia Scholes2. 1. Center for Observational Research, Amgen Inc., Thousand Oaks, CA. Electronic address: leslie.spangler@amgen.com. 2. Group Health Research Institute, Group Health Cooperative, Seattle, WA. 3. Family and Preventive Medicine, University of California, San Diego, CA. 4. Department of Medicine, University of Washington, Seattle, WA.
Abstract
PURPOSE: Oral contraceptive (OC) use can occur throughout a woman's reproductive life span with the potential for long-term impacts on health. To assess potential measurement error in prior OC use, this study compared level of agreement between self-reported prior OC use and pharmacy dispensing data in perimenopausal and/or early postmenopausal women. METHODS: The study's 1399 women (ages, 45-59 years) were participants in a population-based case-control study of the association between OC use and fracture risk. Episodes of lifetime self-reported OC use (in months) were collected, by telephone interview, for January 1, 2008 through November 25, 2012. Pharmacy fills, back to 1980, were collected from automated data. Agreement was measured using the prevalence-adjusted and bias-adjusted kappa index. RESULTS: The number of women with OC pharmacy fills was 11% to 45% higher than those who reported OC use during each time period. Between-measures agreement was better for more recent use. Prevalence-adjusted and bias-adjusted kappa index values ranged from 0.88 (95% confidence interval, 0.85-0.90) within 5 years from the reference date to 0.65 (95% confidence interval, 0.59-0.71) within 15 to 20 years. CONCLUSIONS: For studies designed to assess the long-term effects of OC use, the current results are reassuring in noting moderate agreement between self-reported OC use and pharmacy data for up to 15 to 20 years before the interview.
PURPOSE: Oral contraceptive (OC) use can occur throughout a woman's reproductive life span with the potential for long-term impacts on health. To assess potential measurement error in prior OC use, this study compared level of agreement between self-reported prior OC use and pharmacy dispensing data in perimenopausal and/or early postmenopausal women. METHODS: The study's 1399 women (ages, 45-59 years) were participants in a population-based case-control study of the association between OC use and fracture risk. Episodes of lifetime self-reported OC use (in months) were collected, by telephone interview, for January 1, 2008 through November 25, 2012. Pharmacy fills, back to 1980, were collected from automated data. Agreement was measured using the prevalence-adjusted and bias-adjusted kappa index. RESULTS: The number of women with OC pharmacy fills was 11% to 45% higher than those who reported OC use during each time period. Between-measures agreement was better for more recent use. Prevalence-adjusted and bias-adjusted kappa index values ranged from 0.88 (95% confidence interval, 0.85-0.90) within 5 years from the reference date to 0.65 (95% confidence interval, 0.59-0.71) within 15 to 20 years. CONCLUSIONS: For studies designed to assess the long-term effects of OC use, the current results are reassuring in noting moderate agreement between self-reported OC use and pharmacy data for up to 15 to 20 years before the interview.
Authors: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong-van den Berg Journal: Pharmacoepidemiol Drug Saf Date: 2002 Jul-Aug Impact factor: 2.890
Authors: Eric I Benchimol; Douglas G Manuel; Teresa To; Anne M Griffiths; Linda Rabeneck; Astrid Guttmann Journal: J Clin Epidemiol Date: 2010-12-30 Impact factor: 6.437
Authors: P D Stolley; J A Tonascia; P E Sartwell; M S Tockman; S Tonascia; A Rutledge; R Schinnar Journal: Am J Epidemiol Date: 1978-03 Impact factor: 4.897
Authors: Denise M Boudreau; Mark P Doescher; Barry G Saver; J Elizabeth Jackson; Paul A Fishman Journal: Pharmacoepidemiol Drug Saf Date: 2005-12 Impact factor: 2.890
Authors: Delia Scholes; Andrea Z LaCroix; Rebecca A Hubbard; Laura E Ichikawa; Leslie Spangler; Belinda H Operskalski; Nancy Gell; Susan M Ott Journal: Menopause Date: 2016-02 Impact factor: 2.953
Authors: Lia A Bernardi; Marissa Steinberg Weiss; Anne Waldo; Quaker Harmon; Mercedes R Carnethon; Donna D Baird; Lauren A Wise; Erica E Marsh Journal: Fertil Steril Date: 2021-03-19 Impact factor: 7.490
Authors: Sharon L Achilles; Felix G Mhlanga; Petina Musara; Samuel M Poloyac; Zvavahera M Chirenje; Sharon L Hillier Journal: Contraception Date: 2017-09-28 Impact factor: 3.375